Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The 500 Festival has announced the winners of the float awards for the 2025 AES 500 Festival Parade. The parade is one of the ...

Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...

Purdue University is launching new academic programs, expanding research capabilities and forging partnerships with one ...

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...

The test can aid doctors in determining whether a patient's memory problems are due to Alzheimer's or a number of other ...

Seymour High School’s annual honor day program was held Friday. The event started with the Pledge of Allegiance led by Ismael Santiago Cruz, senior class president, followed by ...

After buying thousands of acres northwest of Indianapolis for a contentious technology park, the Indiana Economic Development ...

FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...

Eli Lilly has unveiled plans to expand its long-standing partnership with Purdue University, with the drugmaker investing up ...

Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...